Skip to main content

Advertisement

Table 4 Health-related quality of life scores by anaemia status in patients with CKD stages 3 and 4 and those on dialysis

From: Cross-sectional survey in CKD patients across Europe describing the association between quality of life and anaemia

Subscales of the KDQOL-36 Non-anaemic
Mean (SD)
Anaemic
Mean (SD)
P-value
Symptoms/problems list 84.9 (15.6) 78.2 (18.0) <0.0001
Effect of Kidney Disease 78.7 (17.7) 67.0 (21.3) <0.0001
Burden of Kidney Disease 63.6 (25.7) 49.9 (26.3) <0.0001
SF-12 physical composite summary 43.1 (9.8) 38.5 (9.9) <0.0001
 CKD stage 3 45.1 (9.1) 42.3 (9.9) 0.0112
 CKD stage 4 40.6 (10.2) 38.0 (9.5) 0.0506
 Dialysis a 39.5 (10.3) 37.3 (9.8) 0.1319
SF-12 mental composite summary 48.5 (9.1) 45.8 (10.0) <0.0001
 CKD stage 3 50.6 (8.2) 47.5 (9.5) 0.0028
 CKD stage 4 46.7 (9.3) 45.5 (9.8) 0.2841
 Dialysis a 43.9 (9.1) 45.2 (10.3) 0.3507
  1. Abbreviations: CKD chronic kidney disease, KDQOL-36 Kidney Disease Quality of Life Instrument, SD standard deviation, SF-12, 12-Item Short Form Health Survey
  2. a Note: Anaemia in dialysis patients may be affected by level of erythropoiesis stimulating agent/iron use (78 % of dialysis patients vs 50 % in CKD stage 4 and 19 % in CKD stage 3, respectively)